Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Amylyx Pharmaceuticals (Nasdaq: AMLX) has announced it will release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025. The company's senior management will host a conference call and audio webcast at 8:00 a.m. ET to discuss financial results and company updates.
Investors can access the conference call by dialing +1 (800) 836-8184 (U.S. & Canada) or +1 (646) 357-8785 (international). A live audio webcast will be available on the company's investor website and archived for 90 days after the event.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 martedì 4 marzo 2025. Il management senior dell'azienda ospiterà una conferenza telefonica e una trasmissione audio in diretta alle 8:00 ET per discutere i risultati finanziari e gli aggiornamenti aziendali.
Gli investitori possono accedere alla conferenza telefonica componendo il numero +1 (800) 836-8184 (U.S. & Canada) o +1 (646) 357-8785 (internazionale). Una trasmissione audio in diretta sarà disponibile sul sito web per gli investitori dell'azienda e archiviata per 90 giorni dopo l'evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el martes 4 de marzo de 2025. La alta dirección de la compañía llevará a cabo una conferencia telefónica y una transmisión de audio en vivo a las 8:00 a.m. ET para discutir los resultados financieros y las actualizaciones de la empresa.
Los inversores pueden acceder a la conferencia telefónica marcando +1 (800) 836-8184 (EE. UU. y Canadá) o +1 (646) 357-8785 (internacional). Una transmisión de audio en vivo estará disponible en el sitio web de inversores de la compañía y se archivará durante 90 días después del evento.
Amylyx Pharmaceuticals (Nasdaq: AMLX)는 2025년 3월 4일 화요일에 2024년 4분기 및 전체 연도 재무 결과를 발표할 것이라고 발표했습니다. 회사의 고위 경영진은 재무 결과 및 회사 업데이트에 대해 논의하기 위해 동부 표준시 오전 8시에 전화 회의 및 오디오 웹캐스트를 주최할 것입니다.
투자자는 +1 (800) 836-8184 (미국 및 캐나다) 또는 +1 (646) 357-8785 (국제)로 전화하여 회의에 접속할 수 있습니다. 실시간 오디오 웹캐스트는 회사의 투자자 웹사이트에서 이용 가능하며 이벤트 후 90일 동안 아카이브됩니다.
Amylyx Pharmaceuticals (Nasdaq: AMLX) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le mardi 4 mars 2025. La direction senior de l'entreprise animera une conférence téléphonique et un webcast audio à 8h00 ET pour discuter des résultats financiers et des mises à jour de l'entreprise.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le +1 (800) 836-8184 (États-Unis et Canada) ou le +1 (646) 357-8785 (international). Un webcast audio en direct sera disponible sur le site Web des investisseurs de l'entreprise et archivé pendant 90 jours après l'événement.
Amylyx Pharmaceuticals (Nasdaq: AMLX) hat angekündigt, dass es am Dienstag, den 4. März 2025, seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 veröffentlichen wird. Das Senior Management des Unternehmens wird um 8:00 Uhr ET eine Telefonkonferenz und einen Audio-Webcast abhalten, um die Finanzergebnisse und Unternehmensaktualisierungen zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie +1 (800) 836-8184 (USA & Kanada) oder +1 (646) 357-8785 (international) wählen. Ein Live-Audio-Webcast wird auf der Investorenseite des Unternehmens verfügbar sein und 90 Tage nach der Veranstaltung archiviert werden.
- None.
- None.
To access the conference call, please dial +1 (800) 836-8184 (
About Amylyx Pharmaceuticals
At Amylyx, our mission is to usher in a new era of treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are currently focused on three investigational therapies across several neurodegenerative, neuroendocrine, and endocrine diseases in which we believe they can make the greatest impact. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224661452/en/
Media
Amylyx Media Team
+1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors
Lindsey Allen
Amylyx Pharmaceuticals, Inc.
+1 (857) 320-6244
Investors@amylyx.com
Source: Amylyx Pharmaceuticals, Inc.
FAQ
When will Amylyx Pharmaceuticals (AMLX) report Q4 and full year 2024 earnings?
What time is the AMLX Q4 2024 earnings call?
How can investors access the AMLX Q4 2024 earnings call?
How long will the AMLX Q4 2024 earnings webcast be available for replay?
